They may have lost the latest round in the patent dispute, but Jennifer Doudna and Emmanuelle Charpentier will be forever celebrated as the inventors of CRISPR.
In “The Code Breaker” by Walter Isaacson, Doudna tells how a school’s guidance counselor tried to discourage her from studying chemistry at college: “Girls don’t do science.”
The Nobel prize came a few decades and many brilliant experiments later, it’s the first shared by two women. The institute founded by Doudna (IGI) is now launching an ad hoc incubator specifically to enhance gender equity in bio-entrepreneurship. Jennifer and Emmanuelle are unquestionably great role models for girls interested in science and started a wave of discoveries and inventions by female scientists.
In the slideshow below, you can meet some of the brightest women in CRISPR.
The first Investigational New Drug (IND) application for base-editing technology has been cleared by the Food and Drug Administration. BEAM-101, developed by Beam Therapeutics, is an ex vivo base-editing product candidate, meaning that it uses a modified form of CRISPR capable of making single base changes without double-stranded DNA cleavage.Continue reading